Cheil Bio Co Ltd 052670
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- KRW 2,055.00–2,345.00
- 52-Week Range
- —–—
- Bid/Ask
- KRW 0.00 / KRW 0.00
- Market Cap
- KRW 56.18 Bil
- Volume/Avg
- 316,687 / 0
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.70
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 5.34%
Company Profile
Cheil Bio Co Ltd is a Korea-based company involved in the manufacturing of veterinary drugs. Its offerings consist of antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, diagnostic kits including enzyme-linked immunosorbent assay (ELISA) test kits, virus test kits, and deoxyribonucleic acid (DNA) kits, as well as feed additives. The company's products are used for cattle, pigs, chickens, pets and other animals.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 59
- Website
- http://www.cheilbio.com
Valuation
|
Metric
|
052670
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.75 |
Price/Sales | 4.70 |
Price/Cash Flow | — |
Price/Earnings
052670
Financial Strength
|
Metric
|
052670
|
|---|---|
Quick Ratio | 10.61 |
Current Ratio | 13.22 |
Interest Coverage | −106.20 |
Quick Ratio
052670
Profitability
|
Metric
|
052670
|
|---|---|
Return on Assets (Normalized) | −3.68% |
Return on Equity (Normalized) | −3.87% |
Return on Invested Capital (Normalized) | −6.03% |
Return on Assets
052670
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Xxxlplcb | Mxtq | $70.0 Bil | |
MKKGY
| Merck KGaA ADR | Gjxcvjkqrt | Ycqcr | $68.1 Bil | |
HLN
| Haleon PLC ADR | Sbrmvhbqj | Xbjds | $36.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Hkxzcblqp | Zjctw | $14.3 Bil | |
VTRS
| Viatris Inc | Kxwgxwwj | Gdfd | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Jzldmbk | Cfw | $11.9 Bil | |
CTLT
| Catalent Inc | Mgwcdkrk | Bzcykw | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Scrfcdsq | Kxhvt | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Vsqhrxsq | Bss | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Vgfmyjynr | Jmvlly | $3.4 Bil |